Financials in USD. Standardized financial statements.
A compact view of how Notable Labs, Ltd. turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $310,000 | $8,000 | $285,000 | $922,000 | $562,000 | $585,000 | $13.86M | $0 | $0 |
| Revenue Growth? | +3775.0% | -97.2% | -69.1% | +64.1% | -3.9% | -95.8% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $197,000 | $1.16M | $1.62M | $1.59M | $1.44M | $1.39M | $496,000 | $130,000 | $122,000 |
| Gross Profit? | $113,000 | -$1.15M | -$1.34M | -$666,000 | -$879,000 | -$806,000 | $13.37M | -$130,000 | -$122,000 |
| Gross Margin? | +36.5% | -14425.0% | -468.8% | -72.2% | -156.4% | -137.8% | +96.4% | 0.0% | 0.0% |
| Operating Expenses? | $14.77M | $12.93M | $17.20M | $23.82M | $19.20M | $22.42M | $26.21M | $17.84M | $16.60M |
| Operating Income? | -$14.66M | -$12.92M | -$16.91M | -$24.48M | -$20.08M | -$23.22M | -$12.84M | -$17.98M | -$16.72M |
| EBITDA? | -$14.40M | -$12.60M | -$16.59M | -$22.93M | -$17.99M | -$22.07M | -$12.69M | -$17.84M | -$16.60M |
| Income Before Tax | -$11.26M | -$14.41M | -$16.05M | -$24.23M | -$19.40M | -$20.46M | -$10.14M | -$16.00M | -$14.89M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$11.26M | -$14.41M | -$16.05M | -$24.23M | -$19.40M | -$20.46M | -$10.14M | -$16.00M | -$14.89M |
| EPS? | $-5.03 | $-6.50 | $-0.22 | $-0.48 | $-0.38 | $-0.62 | $-0.37 | $-0.64 | $-0.73 |
| Diluted EPS? | $-5.03 | $-6.50 | $-0.22 | $-0.48 | $-0.38 | $-0.62 | $-0.37 | $-0.64 | $-0.73 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality